Trial Profile
In-hospital major bleeding and mortality associated with Bivalirudin versus Unfractionated Heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Acute coronary syndromes; Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2016 New trial record